Avinger (NASDAQ:AVGR) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Avinger (NASDAQ:AVGR) in a research report sent to investors on Thursday morning. The firm issued a hold rating on the medical device company’s stock.

Separately, HC Wainwright reaffirmed a buy rating and issued a $5.00 price target on shares of Avinger in a research note on Thursday, March 21st.

Avinger Stock Performance

Shares of AVGR stock opened at $3.90 on Thursday. Avinger has a 52-week low of $2.50 and a 52-week high of $18.00. The stock has a market cap of $6.20 million, a price-to-earnings ratio of -0.15 and a beta of 1.22. The firm has a fifty day moving average of $3.46 and a 200-day moving average of $3.26.

Avinger (NASDAQ:AVGR) last released its quarterly earnings results on Wednesday, March 20th. The medical device company reported ($3.93) EPS for the quarter, missing analysts’ consensus estimates of $0.64 by ($4.57). The company had revenue of $1.91 million during the quarter, compared to analyst estimates of $2.52 million. On average, sell-side analysts predict that Avinger will post -2.08 earnings per share for the current year.

About Avinger

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.